Carmell Therapeutics Corp... (CTCX)
NASDAQ: CTCX
· Real-Time Price · USD
0.20
0.01 (2.77%)
At close: Mar 07, 2025, 3:55 PM
Carmell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -3.98M | -3.3M | -3.55M | 3.16M | -19.5M | 317.51K | 576.07K | -3.12M | -5.06M | -346.99K | -527.53K | -234.5K | -87.3K |
Depreciation & Amortization | -270.76K | 58.27K | 57.57K | -349.38K | 423.8K | 62.09K | 59.91K | 59.59K | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 560.87K | 163.7K | 211.47K | 62.38K | 237.76K | 187.03K | 180.51K | 160.07K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -740.84K | 2.59K | 1.42M | -6.68M | 2.79M | 1.54M | 927.79K | 494.13K | 383.96K | 242.64K | 383.47K | 298.97K | -283.92K |
Other Non-Cash Items | 7.08M | 2.13M | 1.38M | -25.06K | 14.27M | -1.87M | -1.68M | -942.09K | 3.28M | -205.3K | -7.61K | -135.4K | -2.65K |
Deferred Income Tax | n/a | n/a | n/a | -324.31K | n/a | n/a | n/a | 942.09K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -927.79K | -185.47K | 1.29M | -5.67M | -228.76K | 1.54M | 927.79K | 596.39K | 849.6K | 509.05K | 383.47K | 298.97K | -283.92K |
Operating Cash Flow | 2.45M | -1.14M | -1.08M | -3.14M | -5.03M | -5.89K | -171.53K | -2.3M | -934.63K | -43.24K | -151.67K | -70.93K | -373.88K |
Capital Expenditures | n/a | -4 | n/a | n/a | -30.47K | n/a | n/a | -3.58K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | -748.8K | n/a | 663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -154.44M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -748.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -748.8K | n/a | -748.8K | -663K | 632.53K | -30.47K | n/a | -3.58K | n/a | n/a | n/a | n/a | -154.44M |
Debt Repayment | 341.68K | -211.1K | -227.26K | -445.2K | -3.09M | 473.5K | 375K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.25M | 2.66M | 31.54K | -803.42K | 15.46M | 25.88K | n/a | 1.58M | 1.16M | -27.79K | -27.79K | -4.53K | -56.23K |
Financial Cash Flow | 2.59M | 2.44M | -195.73K | -1.25M | 12.41M | -375K | 375K | 2.42M | 1.16M | -27.79K | -27.79K | -4.53K | 155.66M |
Net Cash Flow | 7.04M | 1.31M | -7.08M | -5.06M | 7.96M | -5.89K | -171.53K | 117.27K | -540.62K | -43.24K | -179.46K | -75.45K | 849.65K |
Free Cash Flow | 2.45M | -1.14M | -1.08M | -3.14M | -5.06M | -5.89K | -171.53K | -2.3M | -934.63K | -43.24K | -151.67K | -70.93K | -373.88K |